Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

JAZZJazz PharmaceuticalsSigning up patients

Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma

Advanced Pheochromocytoma and Paraganglioma · PCPG

2Calmworry score, out of 100

No strong warning signs right now. The score counts warning signs; it is not a prediction.

Why this score

  • 3 insiders sold shares within a month

    Since May 28, 2026 · was worth 10, fading over time

    +1.5
Worry score2

Score over time

Stage
Phase 2
Patients
90 (planned)
Started
Jan 2, 2026
Main results expected
Dec 15, 2028
Fully finished
Dec 15, 2028
Results posted
not yet

What counts as success

The trial's main goal(s), called the “primary outcome.”

  • Overall Response Rate (ORR) by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1

    Measured over: Up to 36 months.

Changes Tremor has spotted

No changes since Tremor started watching this trial.
Show details (technical version)

Score inputs

  • insider_selling_cluster: base 10, now 1.5, since 2026-05-28, fades (half-life)

Raw record changes

  • none yet

Trial ID NCT07282587 · record last updated 2026-10-29 · checked 2026-11-09 15:47 UTC

See the official record on ClinicalTrials.gov (NCT07282587) ↗